325 related articles for article (PubMed ID: 25234236)
1. Shorter leukocyte telomere length is independently associated with poor survival in patients with bladder cancer.
Russo A; Modica F; Guarrera S; Fiorito G; Pardini B; Viberti C; Allione A; Critelli R; Bosio A; Casetta G; Cucchiarale G; Destefanis P; Gontero P; Rolle L; Zitella A; Fontana D; Frea B; Vineis P; Sacerdote C; Matullo G
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2439-46. PubMed ID: 25234236
[TBL] [Abstract][Full Text] [Related]
2. Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.
Martinez-Delgado B; Gallardo M; Tanic M; Yanowsky K; Inglada-Perez L; Barroso A; Rodriguez-Pinilla M; Cañamero M; Blasco MA; Benitez J
Breast Cancer Res Treat; 2013 Sep; 141(2):231-42. PubMed ID: 24036693
[TBL] [Abstract][Full Text] [Related]
3. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
4. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.
Broberg K; Björk J; Paulsson K; Höglund M; Albin M
Carcinogenesis; 2005 Jul; 26(7):1263-71. PubMed ID: 15746160
[TBL] [Abstract][Full Text] [Related]
5. Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.
Alkhateeb SS; Van Rhijn BW; Finelli A; van der Kwast T; Evans A; Hanna S; Vajpeyi R; Fleshner NE; Jewett MA; Zlotta AR
J Urol; 2010 Jul; 184(1):81-6. PubMed ID: 20478593
[TBL] [Abstract][Full Text] [Related]
6. Shorter recurrence-free survival time, higher risk of multiple recurrences: a retrospective study of non-muscle invasive bladder cancer after transurethral resection.
Deng N; Chen JX; Chen LW; Qiu SP; Li XF; Wang DH
Chin Med J (Engl); 2012 Oct; 125(20):3681-6. PubMed ID: 23075724
[TBL] [Abstract][Full Text] [Related]
7. Telomere length, cigarette smoking, and bladder cancer risk in men and women.
McGrath M; Wong JY; Michaud D; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):815-9. PubMed ID: 17416776
[TBL] [Abstract][Full Text] [Related]
8. Short telomere length, cancer survival, and cancer risk in 47102 individuals.
Weischer M; Nordestgaard BG; Cawthon RM; Freiberg JJ; Tybjærg-Hansen A; Bojesen SE
J Natl Cancer Inst; 2013 Apr; 105(7):459-68. PubMed ID: 23468462
[TBL] [Abstract][Full Text] [Related]
9. Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma.
Rioja J; Bandrés E; Rosell Costa D; Rincón A; López I; Zudaire Bergera JJ; García Foncillas J; Gil MJ; Panizo A; Plaza L; Rioja LA; Berián Polo JM
BJU Int; 2011 Jun; 107(11):1833-8. PubMed ID: 20840328
[TBL] [Abstract][Full Text] [Related]
10. Telomere Length and Breast Cancer Prognosis: A Systematic Review.
Ennour-Idrissi K; Maunsell E; Diorio C
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):3-10. PubMed ID: 27677729
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer survival is associated with telomere length in peripheral blood cells.
Svenson U; Nordfjäll K; Stegmayr B; Manjer J; Nilsson P; Tavelin B; Henriksson R; Lenner P; Roos G
Cancer Res; 2008 May; 68(10):3618-23. PubMed ID: 18483243
[TBL] [Abstract][Full Text] [Related]
13. Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients.
Lin J; Blalock JA; Chen M; Ye Y; Gu J; Cohen L; Cinciripini PM; Wu X
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):336-43. PubMed ID: 25416716
[TBL] [Abstract][Full Text] [Related]
14. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
[TBL] [Abstract][Full Text] [Related]
15. Short telomere length and its correlation with gene mutations in myelodysplastic syndrome.
Hwang SM; Kim SY; Kim JA; Park HS; Park SN; Im K; Kim K; Kim SM; Lee DS
J Hematol Oncol; 2016 Jul; 9(1):62. PubMed ID: 27465399
[TBL] [Abstract][Full Text] [Related]
16. Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing's syndrome.
Aulinas A; Ramírez MJ; Barahona MJ; Valassi E; Resmini E; Mato E; Santos A; Crespo I; Bell O; Surrallés J; Webb SM
PLoS One; 2015; 10(3):e0120185. PubMed ID: 25799396
[TBL] [Abstract][Full Text] [Related]
17. Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases.
Martinez-Delgado B; Yanowsky K; Inglada-Perez L; de la Hoya M; Caldes T; Vega A; Blanco A; Martin T; Gonzalez-Sarmiento R; Blasco M; Robledo M; Urioste M; Song H; Pharoah P; Benitez J
J Med Genet; 2012 May; 49(5):341-4. PubMed ID: 22493152
[TBL] [Abstract][Full Text] [Related]
18. Association of shorter leukocyte telomere repeat length with dementia and mortality.
Honig LS; Kang MS; Schupf N; Lee JH; Mayeux R
Arch Neurol; 2012 Oct; 69(10):1332-9. PubMed ID: 22825311
[TBL] [Abstract][Full Text] [Related]
19. Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity.
Spyridopoulos I; Hoffmann J; Aicher A; Brümmendorf TH; Doerr HW; Zeiher AM; Dimmeler S
Circulation; 2009 Oct; 120(14):1364-72. PubMed ID: 19770396
[TBL] [Abstract][Full Text] [Related]
20. Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families.
Renault AL; Mebirouk N; Cavaciuti E; Le Gal D; Lecarpentier J; d'Enghien CD; Laugé A; Dondon MG; Labbé M; Lesca G; Leroux D; Gladieff L; Adenis C; Faivre L; Gilbert-Dussardier B; Lortholary A; Fricker JP; Dahan K; Bay JO; Longy M; Buecher B; Janin N; Zattara H; Berthet P; Combès A; Coupier I; ; Hall J; Stoppa-Lyonnet D; Andrieu N; Lesueur F
Carcinogenesis; 2017 Oct; 38(10):994-1003. PubMed ID: 28981872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
